Clinical Trials Transformation Initiative

The Clinical Trials Transformation Initiative (CTTI), cofounded by Duke University and the U.S. Food and Drug Administration (FDA), and hosted by Duke, identifies and promotes practices that will increase the quality and efficiency of clinical trials. CTTI executes its mission through the conduct of projects that generate empirical data and lead to consensus-driven, evidence-based recommendations for improving trials.